Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Return on equity (%)

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndReturn on equity (%) (Million JPY)YoY (%)
Dec 31, 20251.7-294.38%
Dec 31, 2024-0.9-93.36%
Dec 31, 2023-13.4+4.28%
Dec 31, 2022-12.9-61.75%
Dec 31, 2021-33.6+118.31%
Sep 30, 2021-15.4+4.76%
Sep 30, 2020-14.7-79.94%
Sep 30, 2019-73.3+823.05%
Sep 30, 2018-7.9-246.77%
Sep 30, 20175.4+5.05%
Sep 30, 20165.2+26.85%
Sep 30, 20154.1+123.08%
Sep 30, 20141.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat